AP957A - Novel stable liquid paracetamol compositions, and method for preparing same. - Google Patents

Novel stable liquid paracetamol compositions, and method for preparing same. Download PDF

Info

Publication number
AP957A
AP957A APAP/P/1998/001223A AP9801223A AP957A AP 957 A AP957 A AP 957A AP 9801223 A AP9801223 A AP 9801223A AP 957 A AP957 A AP 957A
Authority
AP
ARIPO
Prior art keywords
paracetamol
stable
liquid formulations
formulations according
solution
Prior art date
Application number
APAP/P/1998/001223A
Other languages
English (en)
Other versions
AP9801223A0 (en
Inventor
Francois Dietlin
Daniéle Fredj
Original Assignee
Scr Pharmatop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP957(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scr Pharmatop filed Critical Scr Pharmatop
Publication of AP9801223A0 publication Critical patent/AP9801223A0/xx
Application granted granted Critical
Publication of AP957A publication Critical patent/AP957A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
APAP/P/1998/001223A 1996-08-05 1997-08-05 Novel stable liquid paracetamol compositions, and method for preparing same. AP957A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609858A FR2751875B1 (fr) 1996-08-05 1996-08-05 Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation

Publications (2)

Publication Number Publication Date
AP9801223A0 AP9801223A0 (en) 1998-06-30
AP957A true AP957A (en) 2001-04-12

Family

ID=9494820

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1998/001223A AP957A (en) 1996-08-05 1997-08-05 Novel stable liquid paracetamol compositions, and method for preparing same.

Country Status (23)

Country Link
US (1) US6028222A (de)
EP (1) EP0858329B1 (de)
JP (2) JP5060681B2 (de)
KR (1) KR100521235B1 (de)
CN (1) CN1133426C (de)
AP (1) AP957A (de)
AT (1) ATE241972T1 (de)
AU (1) AU742576B2 (de)
BR (1) BR9702362A (de)
CA (1) CA2233924C (de)
CZ (1) CZ298427B6 (de)
DE (1) DE69722580T2 (de)
DK (1) DK0858329T3 (de)
ES (1) ES2201316T3 (de)
FR (1) FR2751875B1 (de)
HU (1) HU226117B1 (de)
MX (1) MX9802734A (de)
NZ (1) NZ330136A (de)
OA (1) OA10678A (de)
PL (1) PL193104B1 (de)
PT (1) PT858329E (de)
RU (1) RU2192249C2 (de)
WO (1) WO1998005314A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160020A (en) * 1996-12-20 2000-12-12 Mcneill-Ppc, Inc. Alkali metal and alkaline-earth metal salts of acetaminophen
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
FR2779061B1 (fr) * 1998-04-14 2004-08-20 Pharmatop Nouveau procede de stabilisation de composes phenoliques et les compositions pharmaceutiques en resultant
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
PL206463B1 (pl) * 1999-05-28 2010-08-31 Novartis Ag Sposób sterylizacji ściskanego opakowania wyrobu farmaceutycznego
DE19932157A1 (de) * 1999-07-13 2001-01-18 Pharmasol Gmbh Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
US6334859B1 (en) 1999-07-26 2002-01-01 Zuli Holdings Ltd. Subcutaneous apparatus and subcutaneous method for treating bodily tissues with electricity or medicaments
IT1313579B1 (it) * 1999-07-30 2002-09-09 Acraf Composizione farmaceutica liquida a base di paracetamolo.
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
AU2006203741B2 (en) * 2000-06-06 2009-11-05 Scr Pharmatop Method for obtaining aqueous formulations with active principles susceptible to oxidation and the aqueous solutions thus obtained
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
EP1469885A1 (de) * 2001-12-18 2004-10-27 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Parenterale paracetamol-zusammensetzung
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
BG65674B1 (bg) * 2003-07-10 2009-06-30 Нихфи Ад Течна форма на комбинирано лекарствено средство за лечение на простудни и грипни заболявания
ATE454905T1 (de) * 2004-03-10 2010-01-15 Shimoda Biotech Pty Ltd Stabile injizierbare diclofenac- zubereitungen
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid
DE102005037653A1 (de) * 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
US20070098790A1 (en) * 2005-10-31 2007-05-03 David Jiang Nutritional supplement for the enhancement of the health of the liver
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.
JP5823093B2 (ja) * 2006-03-28 2015-11-25 ジャヴェリン ファーマシューティカルズ インコーポレイテッド 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
AU2006346318B2 (en) * 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
EP1992334A1 (de) * 2007-05-08 2008-11-19 Docpharma NV/SA Lagerfähige Formulierung eines oxidationsempfindlichen phenolhaltigen Arzneimittels, insbesondere Paracetamol, mit einer wässrigen, durch ein temperaturgeregeltes Herstellungsverfahren desoxidierten Arzneimittellösung
AR067048A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
AR067047A1 (es) * 2007-06-18 2009-09-30 Combino Pharm Sl Formulaciones acuosas de acetaminofen para inyeccion.
CA2705733C (en) 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
WO2009157010A1 (en) * 2008-06-25 2009-12-30 Akums Drugs And Pharmaceuticals Limited An intravenous drug delivery system
WO2009157009A1 (en) * 2008-06-25 2009-12-30 Akums Drugs And Pharmaceuticals Limited An intravenous drug delivery system
EP2243477A1 (de) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US20110014285A1 (en) * 2009-07-15 2011-01-20 Herzenberg Leonore A N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
HUE027032T2 (en) 2009-07-23 2016-08-29 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S A Stable, immediate injectable paracetamol preparation
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
EP2464332B1 (de) 2009-08-13 2016-03-02 Neogen N.V. Lagerstabile formulierung von paracetamol in einer wässrigen lösung
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
EP2308463A1 (de) * 2009-10-12 2011-04-13 EMP Pharma GmbH Wässrige Acetaminophenzusammensetzungen und Herstellungsverfahren
US20120245230A1 (en) 2009-12-10 2012-09-27 Tecnimede-Sociedade Tecnico- Medicinal, S.A. Method and composition for preparing stable liquid formulations of paracetamol
RU2446799C2 (ru) * 2010-01-22 2012-04-10 Анатолий Брониславович Гаврилов Антиоксидантная композиция
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
EP2377516B1 (de) * 2010-04-14 2012-06-20 B. Braun Melsungen AG Acetaminophenzusammensetzung
GR1007315B (el) * 2010-04-19 2011-06-14 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, Υγρομορφη παρεντερικης χορηγησης συνθεση που περιλαμβανει τραμαδολη hci και παρακεταμολη
ES2403121T3 (es) 2010-05-19 2013-05-14 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Formulación de paracetamol inyectable, estable, lista para usar
EP2389931A1 (de) 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Wässrige pharmazeutische Zusammensetzungen mit Liponsäure als Antioxidationsmittel
PT2588097T (pt) * 2010-06-30 2021-05-25 Troikaa Pharmaceuticals Ltd Composições farmacêuticas que compreendem paracetamol e processo para preparar as mesmas
US9452216B2 (en) 2010-12-09 2016-09-27 Maruishi Pharmaceutical Co., Ltd. Agent for stabilizing acetaminophen
AU2011200289B2 (en) * 2011-01-24 2016-10-13 Ioulia Tseti Stable ready to use injectable paracetamol formulation
CN102600068A (zh) * 2011-01-24 2012-07-25 联康药业克雷恩特塞提斯制药实验室有限责任公司 稳定即用的可注射扑热息痛制剂
EP2672955A1 (de) 2011-02-10 2013-12-18 Neogen N.V. Lagerstabile formulierung von paracetamol in einer wässrigen lösung
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
ZA201300398B (en) 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
TW202348234A (zh) 2013-12-24 2023-12-16 維吉尼亞聯邦大學 氧化膽固醇硫酸鹽（ｏｃｓ）之用途
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
WO2016013049A1 (en) 2014-07-25 2016-01-28 Terumo Kabushiki Kaisha Packaged acetaminophen injection solution preparation
KR20170099911A (ko) 2014-12-20 2017-09-01 트로이카 파마슈티칼스 리미티드 파라세타몰 주사 제제
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
ES2867392T3 (es) 2016-02-05 2021-10-20 Innopharma Inc Procedimiento de fabricación de una bolsa de perfusión estable y lista para usar para una formulación sensible a la oxidación
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations
EP3515412A1 (de) * 2016-09-23 2019-07-31 Grünenthal GmbH Stabile formulierung zur parenteralen verabreichung von tapentadol
EP3574894B1 (de) * 2017-01-24 2023-10-04 Woosung Pharmaceutical Co., Ltd. Einspritzzusammensetzung mit acetaminophen
CA3051467C (en) 2017-01-30 2022-11-29 Nevakar, Inc Norepinephrine compositions and methods therefor
WO2018192664A1 (en) * 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
RU2737852C2 (ru) * 2017-12-28 2020-12-03 Беккер Герман Петрович Способ получения лекарственного средства на основе олигопептида аллоферона-1, имеющего противовирусную и иммуномодулирующую направленность, и лекарственное средство увеличенного срока хранения, полученное с его помощью
CN115385818B (zh) * 2022-09-01 2023-09-29 江苏海洋大学 一种扑热息痛杂质及制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314989A (en) * 1980-05-07 1982-02-09 Rosen Gerald M Methionine sulfoxide amflioration of acetaminophen toxicity
US5474757A (en) * 1992-10-16 1995-12-12 Rutgers University Prevention of acetaminophen overdose toxicity with organosulfur compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO82841A2 (ro) * 1981-08-04 1983-11-01 Intreprinderea De Medicamente "Biofarm",Ro Suspensie cu paracetamol
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
FR2646773B1 (fr) * 1989-05-12 1994-05-13 Chauvin Sa Laboratoire Composition pharmaceutique a base de paracetamol
JPH0714872B2 (ja) * 1990-02-06 1995-02-22 昭和薬品化工株式会社 シロップ剤組成物
JPH0672897A (ja) * 1991-03-27 1994-03-15 Cullim & Assoc Inc 月経前の及び月経の不快な諸症状を軽減するための組成物
US5252313A (en) * 1991-12-20 1993-10-12 Colgate-Palmolive Company Visually clear gel dentifrice
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
EP0620001A1 (de) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Wässrige pharmazeutische Suspension und Verfahren zu ihrer Herstellung
DE4327462A1 (de) * 1993-08-16 1995-02-23 Carl Heinrich Dr Weischer Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
CZ210496A3 (en) * 1994-01-24 1996-12-11 Procter & Gamble Method improving solution process of difficult-to dissolve pharmaceutically active compounds
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
JPH09286724A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314989A (en) * 1980-05-07 1982-02-09 Rosen Gerald M Methionine sulfoxide amflioration of acetaminophen toxicity
US5474757A (en) * 1992-10-16 1995-12-12 Rutgers University Prevention of acetaminophen overdose toxicity with organosulfur compounds

Also Published As

Publication number Publication date
FR2751875B1 (fr) 1998-12-24
AU742576B2 (en) 2002-01-10
ES2201316T3 (es) 2004-03-16
US6028222A (en) 2000-02-22
DE69722580D1 (de) 2003-07-10
CN1133426C (zh) 2004-01-07
EP0858329B1 (de) 2003-06-04
HUP9901893A2 (hu) 1999-09-28
EP0858329A1 (de) 1998-08-19
MX9802734A (es) 1998-11-30
ATE241972T1 (de) 2003-06-15
CA2233924A1 (fr) 1998-02-12
JP2010163462A (ja) 2010-07-29
AP9801223A0 (en) 1998-06-30
DE69722580T2 (de) 2004-04-29
DK0858329T3 (da) 2003-09-29
PL193104B1 (pl) 2007-01-31
KR100521235B1 (ko) 2006-01-27
CZ298427B6 (cs) 2007-10-03
OA10678A (fr) 2002-11-20
PT858329E (pt) 2003-09-30
CN1204960A (zh) 1999-01-13
RU2192249C2 (ru) 2002-11-10
JP5122604B2 (ja) 2013-01-16
HUP9901893A3 (en) 2000-06-28
BR9702362A (pt) 1999-12-28
JP5060681B2 (ja) 2012-10-31
AU3945197A (en) 1998-02-25
WO1998005314A1 (fr) 1998-02-12
PL326069A1 (en) 1998-08-17
NZ330136A (en) 2000-03-27
CA2233924C (fr) 2012-08-21
JPH11514013A (ja) 1999-11-30
HU226117B1 (en) 2008-04-28
CZ104898A3 (cs) 1998-09-16
KR19990063978A (ko) 1999-07-26
FR2751875A1 (fr) 1998-02-06

Similar Documents

Publication Publication Date Title
AP957A (en) Novel stable liquid paracetamol compositions, and method for preparing same.
JP5847643B2 (ja) メチルナルトレキソンを含む医薬処方物
TWI342212B (en) Liquid pharmaceutical formulations of palonosetron
EA029478B1 (ru) Стабильные растворы объединенных активных фармацевтических ингредиентов для перорального применения
TWI844703B (zh) 穩定的ast-3424注射液製劑及製備方法
JP2003521518A (ja) モノチオグリセロール、ｌ−システインまたはチオグリコール酸とともにペメトレクストを含む医薬組成物
JP3043381B2 (ja) 葉酸及びロイコボリン塩類の安定で注射液として使用できる薬剤及びその製造方法
UA104381C2 (uk) Стабільна готова до застосування композиція парацетамолу для ін'єкцій
EP1465663A1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
JPWO2008023807A1 (ja) 安定化された医薬組成物
AU2002342826A1 (en) Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
CA3045794A1 (en) Levothyroxine liquid formulations
WO2020011753A1 (en) Compositions for therapeutic uses containing 5-htp and carbidopa
IE50512B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
JP2015164907A (ja) アリピプラゾール含有水性液剤
US20240033215A1 (en) Injectable formulation with enhanced stability containing dexibuprofen and arginin and their medicine vessel for injection
JPH04346926A (ja) シロップ剤